300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Energy
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
Retail
InsurTech
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Manufacturing
Real Estate
Sporting Goods
FinTech
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Finance
Android
Proptech
Impact
Sustainability
Digital Media
Hardware
Biotech
Transportation
Enterprise
Media (Entertainment)
Community
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bolivia
Bahrain
Belize
Algeria
Italy
Belarus
Finland
Estonia
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bahamas
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
SBI US Gateway Fund, VC Fund

SBI US Gateway Fund

VC Fund

Seattle, United States

SBI US Gateway Fund is a VC fund in Seattle focused on Comics and Biopharma. SBI US Gateway is a venture fund. It is a joint fund by SBI Holdings, Inc. and Shin Nippon Biomedical Laboratories in partnership with Plug and Play.

Total investments:
6
Last investment:
Lead investor:
17%

Last updated:

Industries SBI US Gateway Fund invests in

ComicsBiopharmaPublishingHealth CareLife Science

Stages SBI US Gateway Fund invests in

Pre-SeedSeries ASeedVenture - Series Unknown

Countries SBI US Gateway Fund invests in

United States

Investment Focus

Industry

  • Comics 1 (17%)
  • Biopharma 1 (17%)
  • Publishing 1 (17%)
  • Health Care 1 (17%)
  • Life Science 1 (17%)
See all 11 industries →

Stage

  • Pre-Seed 2 (33%)
  • Series A 2 (33%)
  • Seed 1 (17%)
  • Venture - Series Unknown 1 (17%)

Investments

CompanyDescriptionRoundLinks
GlobalComix GlobalComix
GlobalComix is a free digital reading and distribution platform that helps creators and publishers share and sell their comics. GlobalComix helps readers understand the value of artistic labor and help creators earn cash in more consistent and flexible ways. Most importantly, GlobalComix promotes cross-cultural exchange and help comics fans andmakers connect with each other in deeper, more insightful ways. $13M / Venture - Series Unknown / Mar 18, 2026
Avisi Technologies Avisi Technologies
Avisi Technologies develops ophthalmic medical devices using nanotechnology to address vision loss associated with glaucoma and related eye conditions. The company designs implantable solutions such as VisiPlate, an aqueous shunt that regulates intraocular fluid through microchannel structures to help manage eye pressure. Its work combinesmaterials science and ophthalmology to create minimally invasive devices intended for long-term function within the eye. $10.8M / Series A / Feb 25, 2026
Sift Biosciences Sift Biosciences
Sift Biosciences is a biotechnology research company that offers cancer therapies. $3.8M / Pre-Seed / Dec 19, 2025
Hearvana Hearvana
Hearvana is a IT consulting company. $6M / Pre-Seed / Nov 05, 2025
Kite AI Kite AI
Kite AI is a purpose-built, EVM-compatible L1 designed to power the AI economy. $18M / Series A / Sep 02, 2025
Kite AI Kite AI
Kite AI is a purpose-built, EVM-compatible L1 designed to power the AI economy. $15M / Seed / Aug 01, 2023

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Energy
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
Retail
InsurTech
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Manufacturing
Real Estate
Sporting Goods
FinTech
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Finance
Android
Proptech
Impact
Sustainability
Digital Media
Hardware
Biotech
Transportation
Enterprise
Media (Entertainment)
Community
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bolivia
Bahrain
Belize
Algeria
Italy
Belarus
Finland
Estonia
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bahamas
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does SBI US Gateway Fund invest in?

SBI US Gateway Fund invests primarily in Comics, Biopharma and Publishing startups, most often at Pre-Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did SBI US Gateway Fund last invest?

The most recent investment recorded for SBI US Gateway Fund closed in Mar 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
SBI US Gateway Fund SBI US Gateway Fund Find emails